Chapter review

Fitzgerald PMHNP board review. ch17. Prescribing in the Older Adult: Doing More by Doing Less. This is drive 2 of 4. When I say Pause. Answer. wait, then I will give the answer. New section. Deprescribing and 'doing more by doing less' rules from this chapter. Topic. Non-Pharmacological First-Line Options. Fitzgerald Chapter 17: Prescribing in the Older Adult - Non-Pharmacological First-Line Options. Quick Answer. The selected Fitzgerald certification review sources do not contain Chapter 17 ("Prescribing in the Older Adult: Doing More by Doing Less") or its specific leaf on non-pharmacological first-line options [1-56]. However, the selected materials establish core geriatric care principles, showing that older adults comprise 20% (27 items) of the AANP exam items and requiring non-pharmacological primary prevention strategies, such as environmental illumination to prevent falls, alongside secondary screening and tertiary disease management [14, 21, 47, 53]. Bottom Line. - Older adults account for 20% of the total scored items (27 out of 135 items) on the AANP PMHNP certification exam [14, 47]. - First-line health promotion in older adults requires intervening at the lowest possible level of prevention [16, 49]. - Primary prevention stops health problems before they occur, such as ensuring adequate home illumination for a 76-year-old man with **PTSD** and **OCD** to prevent fall injuries [21, 53]. - Secondary prevention focuses on early detection through screening, such as screening a 76-year-old man for physical, emotional, or financial abuse [21, 53]. - Tertiary prevention minimizes negative outcomes in established illness, such as utilizing an Employee Assistance Program or adjusting medication regimens [18, 22, 51, 55]. - The selected review sources cover general exam architecture and prevention levels, but omit Fitzgerald Chapter 17 text and specific deprescribing rules [1-56]. Must Know for Boards. - Safety alert: Environmental hazards in older adults, such as poor lighting, present immediate physical safety risks that require primary prevention interventions before injury occurs [21, 53]. - Board trap: Confusing primary prevention with secondary screening. Screening tests like **PHQ-9** depression screens or abuse screening detect preclinical or asymptomatic disease (secondary), whereas environmental modifications and vaccinations prevent disease onset entirely (primary) [17, 21, 50, 53]. - First-line approach: Always intervene at the lowest applicable level of prevention to optimize safety and cost-effectiveness in geriatric care [16, 17, 49, 50]. - Life span coverage: The ANCC and AANP certification exams integrate older adult content throughout all domains, testing clinical decision-making across the entire continuum from health promotion to emergency management [8, 12, 14, 37, 43, 47]. Sample Practice Questions. Question 1. In a 76-year-old man with **post-traumatic stress disorder** and **obsessive-compulsive disorder**, ensuring adequate illumination at home is an example of which level of prevention? [21, 53] A) Primary prevention [21, 53] B) Secondary prevention [21, 53] C) Tertiary prevention [21, 53] D) Anticipatory guidance [23, 55] Pause. Answer: A [21, 53] Why it is correct: Ensuring adequate illumination at home is a primary prevention intervention because it prevents environmental injury and falls before a health problem occurs [17, 21, 50, 53]. Why the other choices are wrong: - A: This is the correct option. - B: Secondary prevention involves screening to detect asymptomatic or early-stage disease, such as screening for elder abuse [18, 21, 50, 53]. - C: Tertiary prevention manages an established disease to prevent further target organ damage or complications [18, 51]. - D: Anticipatory guidance involves educating patients on expected developmental or situational transitions rather than environmental disease prevention [23, 55]. Test-taking pearl: Remember that any intervention that prevents a physical injury or illness before it starts is primary prevention [17, 21, 50, 53]. Concept tested: Primary prevention in older adults [21, 53]. Question 2. A 35-year-old man with **bipolar disorder** was recently hospitalized for a manic episode [22, 55]. On returning to work as an accountant in a large company, he accesses his company's employee assistance program (EAP) to facilitate his return to work [22, 55]. This is an example of which prevention strategy? [22, 55] A) Primary prevention [23, 55] B) Secondary prevention [23, 55] C) Tertiary prevention [23, 55] D) Anticipatory guidance [23, 55] Pause. Answer: C [23, 55] Why it is correct: Utilizing an EAP to facilitate work return following hospitalization for an established psychiatric disorder is tertiary prevention because it reduces disease-induced disability and prevents workplace complications [18, 23, 51, 55]. Why the other choices are wrong: - A: Primary prevention aims to prevent disease before it develops [17, 50]. - B: Secondary prevention centers on screening to identify early preclinical disease [18, 50]. - C: This is the correct option. - D: Anticipatory guidance provides proactive counseling for expected life stages rather than post-hospitalization rehabilitation [23, 55]. Test-taking pearl: Rehabilitation, occupational support, and adjusting regimens for known chronic conditions are always tertiary prevention [18, 23, 51, 55]. Concept tested: Tertiary prevention and disease management [23, 55]. Next Study Step. Review Fitzgerald Chapter 14 (Older Adults) or select additional geriatric prescribing sources in the notebook to complete the coverage of non-pharmacological interventions and deprescribing algorithms [14, 47]. Next. Topic. Rule of Titration: Start Low, Go Slow, But Get to Goal. Fitzgerald Chapter 17 ("Prescribing in the Older Adult: Doing More by Doing Less") and the specific leaf ("Rule of Titration: Start Low, Go Slow, But Get to Goal") are not present in the selected sources (`FITZGERALD - Chap 00_ prequel 2025 rev 12.19.pdf` and `FITZGERALD - SettingtheStageforSuccessonthePMHNPCertificationExam_Transcript.pdf`). The selected sources cover exam architecture, domain weights, and health promotion levels of prevention [1-6]. Here is what the selected Fitzgerald materials cover regarding geriatric care, exam distribution, and level of prevention strategies for older adults [7-10]. Bottom Line Summary. * **Older Adult Domain Weight**: Older adults (ages 65 and older) account for 20 percent (27 scored items) of the total AANPCB certification examination [7, 9]. * **Primary Prevention in Older Adults**: Focuses on preventing health problems before they occur, such as ordering an annual influenza vaccine for a 66-year-old patient with schizophrenia or ensuring adequate home lighting for a 76-year-old to prevent falls [3, 6, 11-14]. * **Secondary Prevention in Older Adults**: Focuses on early detection through screening, such as screening a 76-year-old man with PTSD and OCD for physical, emotional, or financial abuse [6, 8, 12, 14]. * **Tertiary Prevention in Older Adults**: Focuses on managing established disease and adjusting therapy to minimize negative disease-induced outcomes and prevent further organ damage, such as adjusting psychotropic medication in a 66-year-old with schizophrenia [8, 10, 11, 13]. * **Lifespan Scope**: Both ANCC and AANPCB exams integrate lifespan content randomly across items rather than dividing content into distinct age blocks [5, 7, 9, 15]. High-Yield Concepts and Levels of Prevention. Primary Prevention in Geriatric Care. - **Definition**: Preventing a health condition before it develops [3, 6]. - **First-line Examples**: Administering the influenza vaccine to older adults, counseling on safety, and ensuring home environmental safety such as proper lighting to prevent falls [3, 6, 11-14]. - **Safety Alert**: Primary prevention is the most cost-effective form of healthcare intervention [3, 6]. Secondary Prevention in Geriatric Care. - **Definition**: Detecting disease in an early, asymptomatic, or preclinical stage to minimize impact [6, 8]. - **First-line Examples**: Performing screening tests, such as checking blood pressure, ordering lipid panels, or screening an older adult for physical, emotional, or financial elder abuse [6, 8, 12, 14, 16]. - **Board Trap**: Do not confuse screening (secondary prevention) with treating or adjusting medication for an already established diagnosis (tertiary prevention) [6, 8, 10]. Tertiary Prevention in Geriatric Care. - **Definition**: Minimizing negative outcomes in patients with established disease [8, 10]. - **First-line Examples**: Adjusting psychotropic medication regimens, optimizing symptom control, and coordinating rehabilitation or employee assistance programs after acute stabilization [8, 10, 11, 13, 17, 18]. - **Safety Alert**: Tertiary prevention can be viewed clinically as a failure of primary prevention, requiring ongoing adjustments to avoid target organ damage or functional decline [8, 10]. Sample Board-Style Practice Questions from Selected Sources. Question 1. In a 66-year-old woman with schizophrenia, ordering an influenza vaccine represents which level of prevention? A) Primary prevention B) Secondary prevention C) Tertiary prevention D) Quaternary prevention Quick Answer. Ordering an influenza vaccine is a primary prevention strategy [11, 13]. Key Clue. Vaccination prevents disease before it occurs [3, 6, 11, 13]. Best Answer. A) Primary prevention [11, 13]. Why It Is Correct. Primary prevention aims to prevent disease before it starts. Administering an immunization prevents viral infection in a vulnerable older adult [3, 6, 11, 13]. Why the Other Choices Are Wrong. - **B:** Secondary prevention involves screening for early asymptomatic disease, not vaccination [6, 8]. - **C:** Tertiary prevention involves managing an existing disease to prevent complications [8, 10]. - **D:** Quaternary prevention is not a standard board-tested level of health promotion [3, 6]. Test-Taking Pearl. Any intervention that prevents an illness from occurring in the first place is always primary prevention [3, 6]. Question 2. In a 76-year-old man with post-traumatic stress disorder and obsessive-compulsive disorder, screening for physical, emotional, or financial abuse is an example of: A) Primary prevention B) Secondary prevention C) Tertiary prevention D) Harm reduction Quick Answer. Screening for abuse is a secondary prevention strategy [12, 14]. Key Clue. The word screening indicates secondary prevention [6, 8, 12, 14]. Best Answer. B) Secondary prevention [12, 14]. Why It Is Correct. Secondary prevention focuses on early detection of preclinical or asymptomatic conditions through screening to minimize long-term harm [6, 8, 12, 14]. Why the Other Choices Are Wrong. - **A:** Primary prevention stops an injury or illness before it happens, such as home lighting modifications [3, 6, 12, 14]. - **C:** Tertiary prevention manages known, established disease complications [8, 10]. - **D:** Harm reduction is a clinical strategy for substance use, not a standard level of prevention category [3, 6, 8]. Test-Taking Pearl. Whenever a question stem mentions screening or early detection, select secondary prevention [6, 8, 12, 14]. Question 3. Adjusting the therapeutic regimen of a 66-year-old patient with schizophrenia to enhance symptom stability is classified as: A) Primary prevention B) Secondary prevention C) Tertiary prevention D) Health promotion Quick Answer. Adjusting therapy for an existing condition is tertiary prevention [11, 13]. Key Clue. Managing established disease to prevent further decline indicates tertiary prevention [8, 10, 11, 13]. Best Answer. C) Tertiary prevention [11, 13]. Why It Is Correct. Tertiary prevention minimizes negative outcomes and prevents complications in a patient with an established diagnosis [8, 10, 11, 13]. Why the Other Choices Are Wrong. - **A:** Primary prevention prevents disease onset [3, 6]. - **B:** Secondary prevention identifies asymptomatic disease through screening [6, 8]. - **D:** Health promotion is a broad concept typically aligned with primary prevention rather than established disease management [3, 6]. Test-Taking Pearl. Managing, titrating, or adjusting treatment for an established chronic condition is always tertiary prevention [8, 10, 11, 13]. 💡 *Would you like to examine Fitzgerald Chapter 14 (Older Adults) or perform web research on Chapter 17?* Next. Topic. Practice Question: Geriatric Depression Treatment Selection. Source Availability Note. The specific text for **Fitzgerald Chapter 17** ("Prescribing in the Older Adult: Doing More by Doing Less") is not included in the provided notebook materials, which cover Chapters 1 through 16 source 1. However, core geriatric prescribing rules, deprescribing principles, and geriatric depression treatment selection are detailed across **Fitzgerald Chapter 14** (Older Adults) source 1, **Chapter 2** (Select Special Topics) source 2, and matching review transcripts [3, 4]. If you would like me to perform web research on Chapter 17 specifically, please ask for confirmation and I will gather those materials for you. Bottom Line Summary. * **First-line**: **Sertraline** and **escitalopram** are preferred **SSRI** choices for geriatric depression due to low anticholinergic activity and favorable drug interaction profiles [2, 5]. * **Safety alert**: **Paroxetine** is listed on **Beers criteria** and should be avoided in older adults due to potent anticholinergic effects, sedation, and CYP2D6 inhibition [2, 6]. * **Safety alert**: **Citalopram** carries a maximum dose limit of **20 mg per day** in patients over age **60 years** due to dose-dependent **QTc prolongation** source 2. * **Board trap**: Assuming a normal **serum creatinine** indicates normal renal clearance in an older adult. Age-related loss of muscle mass masks renal decline, so always check **eGFR** before dosing [2, 7]. * **Safety alert**: **Tricyclic antidepressants** like **amitriptyline** are strongly avoided in older adults due to high anticholinergic burden, orthostatic hypotension, confusion, and fall risk [2, 6]. * **First-line**: **Mirtazapine** is an effective alternative for geriatric depression accompanied by severe **insomnia** or **weight loss** due to its antihistaminic appetite-stimulating and sedating effects at lower doses source 2. * **Board trap**: Prescribing full adult starting doses in elderly patients. Always start low and go slow, but titrate to therapeutic levels to avoid under-treating source 2. High-Yield Concept Review: Geriatric Antidepressant Selection. Sertraline and Escitalopram. * **Fast mental label**: Preferred geriatric SSRIs source 2. * **Priority**: Lowest risk of CYP450 drug interactions and minimal anticholinergic burden source 2. * **Boards are testing**: Recognizing safe first-line prescribing in polypharmacy source 2. Paroxetine. * **Fast mental label**: High-risk geriatric SSRI [2, 6]. * **Priority**: Strong anticholinergic and sedating properties [2, 6]. * **Boards are testing**: Identifying drugs on **Beers criteria** that cause cognitive impairment, constipation, and urinary retention [2, 6]. Citalopram. * **Fast mental label**: Dosed-capped SSRI source 2. * **Priority**: Cardiac safety and **QTc prolongation** monitoring source 2. * **Boards are testing**: Knowing the **20 mg per day** limit for patients older than **60 years** source 2. Amitriptyline and Imipramine. * **Fast mental label**: High-hazard tricyclic antidepressants [2, 6]. * **Priority**: Severe anticholinergic toxicity, sedation, and cardiac conduction delays [2, 6]. * **Boards are testing**: Avoiding TCAs in older adults due to fall and arrhythmia risks [2, 6]. Board-Style Practice Question. Question 1. A 74-year-old woman presents with a 6-week history of depressed mood, anhedonia, early morning awakening, and a 12-pound unintentional weight loss. Her past medical history includes hypertension and mild cognitive impairment. She takes amlodipine daily. Which of the following is the **most appropriate initial** pharmacologic treatment for this patient? A) **Amitriptyline** 25 mg at bedtime B) **Paroxetine** 20 mg daily C) **Sertraline** 25 mg daily D) **Citalopram** 40 mg daily Pause. **Quick Answer**: **Sertraline** started at a low dose is the best choice for this older adult [2, 5]. **Key Clue**: The patient is an older adult with depression requiring a safe **SSRI** with low anticholinergic activity and minimal drug interactions [2, 5]. **Best Answer**: C) **Sertraline** 25 mg daily **Why It Is Correct**: **Sertraline** is a first-line **SSRI** in older adults because it has minimal anticholinergic activity, low cardiac risk, and a favorable cytochrome P450 profile [2, 5]. Dosing in geriatric patients follows the principle of starting low at 25 mg daily and titrating gradually to therapeutic response source 2. **Why the Other Choices Are Wrong**: * **A**: **Amitriptyline** is a tricyclic antidepressant listed on **Beers criteria** that causes severe anticholinergic side effects, confusion, orthostatic hypotension, and increased fall risk [2, 6]. * **B**: **Paroxetine** is avoided in elderly patients due to high anticholinergic potency, sedation, and strong CYP2D6 inhibition [2, 6]. * **D**: **Citalopram** at 40 mg exceeds the maximum recommended dose of **20 mg daily** for patients over **60 years** of age due to the risk of **QTc prolongation** and arrhythmias source 2. **Test-Taking Pearl**: Always pick **sertraline** or **escitalopram** as first-line SSRIs for elderly patients, and remember that **citalopram** is capped at **20 mg daily** in adults over **60 years** [2, 5]. Active Recall Checkpoints. 1. What is the maximum daily dose of **citalopram** in patients over age **60 years** source 2? 2. Why is **paroxetine** avoided in older adults according to **Beers criteria** [2, 6]? 3. Which kidney function lab must be checked instead of **serum creatinine** to evaluate true renal clearance in elderly patients [2, 7]? 4. Which antidepressant is particularly useful for geriatric depression presenting with severe weight loss and insomnia source 2? 5. Why are tricyclic antidepressants like **amitriptyline** dangerous in older adults [2, 6]? 💡 **Next Study Step**: Would you like to review **Fitzgerald Chapter 14 (Older Adults)** for a deeper dive into delirium versus dementia vs depression, or shall I run a web search to extract the exact text for Chapter 17? Next. New section. High-risk psychotropics in older adults and monitoring. Topic. Antipsychotics: Black Box Warning and TD Risk. Bottom Line Summary. * **FDA Black Box Warning**: All **first-generation antipsychotics** (FGAs) and **second-generation antipsychotics** (SGAs) carry a black box warning for an increased risk of all-cause mortality, primarily from cardiovascular events or pneumonia, when administered to older adults with **dementia-related psychosis**. * **Beers Criteria classification**: Antipsychotics are classified as Potentially Inappropriate Medications (PIMs) in geriatrics and must be avoided for **behavioral and psychological symptoms of dementia** (BPSD) unless non-pharmacological strategies have failed and the patient poses an immediate threat of harm to self or others. * **Tardive dyskinesia (TD) vulnerability**: Older adults face a significantly elevated risk of developing **tardive dyskinesia** due to age-related dopaminergic neuronal loss and cumulative neuroleptic exposure; **FGAs** carry a 3 to 5 times higher annual incidence of TD in older adults compared to younger populations. * **AIMS monitoring schedule**: Perform the **Abnormal Involuntary Movement Scale** (AIMS) at baseline before initiating any antipsychotic, and repeat the assessment every 3 to 6 months in older adults or high-risk individuals. * **First-line intervention for BPSD**: Non-pharmacological interventions, including environmental modifications, behavioral redirection, and identifying underlying physical causes like pain or infection, are **first-line** for dementia-related agitation. * **Lower-risk SGA selection**: When antipsychotic therapy is clinically mandatory for severe danger or psychosis, low-dose **SGAs** with low extrapyramidal symptom liability, such as **quetiapine** (12.5 mg to 25 mg daily) or **risperidone** (0.25 mg to 0.5 mg daily), are preferred over high-potency **FGAs** like **haloperidol**. * **TD management protocol**: If involuntary oro-facial-lingual or choreiform movements occur, discontinue or taper the antipsychotic if clinically safe, switch to a lower-risk **SGA** like **quetiapine** or **clozapine**, or consider VMAT2 inhibitors such as **valbenazine** or **deutetrabenazine**. Clinical Concept Deep Dive. FDA Black Box Warning and Mortality Risk. **Safety alert**: The FDA Black Box Warning applies universally across the entire antipsychotic class, encompassing both **first-generation antipsychotics** (such as **haloperidol** and **fluphenazine**) and **second-generation antipsychotics** (such as **risperidone**, **olanzapine**, **quetiapine**, **aripiprazole**, and **ziprasidone**). Clinical trial data demonstrate a 1.6 to 1.7 times increase in all-cause mortality among elderly patients with **dementia-related psychosis** treated with antipsychotics compared to placebo. The predominant causes of death in these clinical trials were cardiovascular events, including heart failure and sudden cardiac death, as well as infectious complications, particularly pneumonia. Furthermore, antipsychotic use in patients with Alzheimer's disease or vascular dementia increases the incidence of cerebrovascular adverse events, including transient ischemic attacks and stroke. **Board trap**: Exam items frequently present an elderly resident with **dementia** who exhibits mild nighttime agitation, wandering, or uncooperative behavior during bathing, and ask for the **first** or **most appropriate** prescription. Test-takers often succumb to the trap of selecting an **SGA** like **quetiapine** under the false assumption that newer atypical agents are exempt from the Black Box Warning. The board-correct choice is ALWAYS non-pharmacological behavioral management **first**. Antipsychotics must never be prescribed for environmental convenience, wandering, or uncooperative behavior without active danger. Tardive Dyskinesia Risk and AIMS Assessment. **First-line**: Non-pharmacological strategies remain the **first-line** standard of care for non-emergent behavioral distress in neurocognitive disorders. When non-pharmacological methods prove insufficient and severe psychotic distress or physical aggression creates an immediate safety hazard, short-term pharmacotherapy may be initiated using the lowest available starting dose. Older adults possess extreme susceptibility to extrapyramidal symptoms (EPS) and **tardive dyskinesia** due to age-associated declines in nigrostriatal dopaminergic tone, altered central nervous system receptor sensitivity, and reduced hepatic and renal drug clearance. **Tardive dyskinesia** manifests as involuntary, repetitive, choreoathetoid movements affecting the oro-facial-lingual muscles (tongue protrusion, lip smacking, puckering, grimacing) and choreiform movements of the extremities and trunk. To monitor for TD effectively, the PMHNP must administer the **Abnormal Involuntary Movement Scale** (AIMS) prior to initiating any antipsychotic agent to establish a baseline. In older adults, follow-up AIMS examinations must occur every 3 to 6 months, compared to every 6 to 12 months in younger, lower-risk adults. If TD symptoms emerge, the PMHNP should immediately re-evaluate the ongoing need for the antipsychotic, taper or reduce the dosage if safe, or cross-taper to an **SGA** with minimal D2 affinity such as **quetiapine** or **clozapine**. Anticholinergic agents such as **benztropine** treat drug-induced parkinsonism but exacerbate or unmask **tardive dyskinesia** and are strictly contraindicated for TD. Targeted pharmacological treatment for persistent TD includes VMAT2 inhibitors like **valbenazine** and **deutetrabenazine**. High-Risk Comparison Block. First-Generation Antipsychotics vs Second-Generation Antipsychotics in Older Adults. * **Do not confuse**: Both FGAs and SGAs carry the identical FDA Black Box Warning for increased mortality in **dementia-related psychosis**, but their adverse effect profiles differ significantly. * **Think FGAs (e.g., Haloperidol) when**: High-potency D2 receptor antagonism creates severe risk for acute dystonia, drug-induced parkinsonism, and **tardive dyskinesia** in older adults. * **Think SGAs (e.g., Quetiapine, Risperidone) when**: Serotonin 5-HT2A and lower D2 receptor affinity reduce EPS and TD risk, but increase the incidence of metabolic syndrome, orthostatic hypotension, sedation, and falls. * **Priority difference**: Neither class is indicated for routine dementia behavior, but if emergency chemical stabilization is required for acute physical danger, low-dose **SGAs** are preferred over **FGAs** to reduce motor toxicity. * **Boards are testing**: Recognition that selecting an **SGA** over an **FGA** does not eliminate the Black Box Warning for mortality in older adults with dementia. * **Classic distractor**: Choosing **quetiapine** under the mistaken belief that its lower EPS risk makes it FDA-approved for dementia-related agitation. Tardive Dyskinesia vs Drug-Induced Parkinsonism. * **Do not confuse**: Both conditions represent motor complications of antipsychotic D2 blockade, but their clinical presentations and pharmacological management are directly opposing. * **Think Tardive Dyskinesia when**: Involuntary, hyperkinetic, choreoathetoid movements (lip smacking, tongue rolling, facial grimacing) appearing after prolonged antipsychotic exposure; symptoms worsen with anticholinergic administration. * **Think Drug-Induced Parkinsonism when**: Hypokinetic rigidity, bradykinesia, resting tremor, and a shuffling gait appearing within days to weeks of starting or escalating an antipsychotic; symptoms improve with anticholinergics or dose reduction. * **Priority difference**: Administering an anticholinergic like **benztropine** relieves parkinsonian rigidity but worsens or unmasks **tardive dyskinesia**. * **Boards are testing**: Distinguishing hyperkinetic involuntary movements (TD) from hypokinetic muscle stiffness (parkinsonism) prior to selecting an intervention. * **Classic distractor**: Ordering **benztropine** for an elderly patient displaying involuntary tongue protrusion and lip puckering. Board-Style Practice Question Bank. Question 1. An 82-year-old female with moderate Alzheimer's disease resides in a memory care facility. Her family reports that over the past two weeks, she has become increasingly restless in the late afternoon, pacing the hallways and asking to go home. She has no fever, dysuria, or physical distress, and her vital signs are normal. The facility staff ask the PMHNP to prescribe low-dose haloperidol to manage her evening agitation. What is the most appropriate initial action by the PMHNP? A) Initiate haloperidol 0.5 mg orally at bedtime. B) Order quetiapine 12.5 mg orally twice daily. C) Recommend non-pharmacological environmental modifications and behavioral strategies. D) Obtain a STAT computed tomography scan of the head. Pause. Answer: C. Why correct: Non-pharmacological strategies represent the first-line intervention for behavioral and psychological symptoms of dementia. Antipsychotics carry an FDA Black Box Warning for increased mortality in elderly patients with dementia-related psychosis and should only be used when non-pharmacological efforts fail and the patient poses an immediate danger to self or others. Why each distractor fails: * A: Initiating haloperidol violates the Black Box Warning and Beers Criteria guidelines by using a high-potency FGA for non-dangerous agitation without attempting non-pharmacological measures first. * B: Prescribing quetiapine is inappropriate because SGAs carry the same FDA Black Box Warning for increased mortality in dementia-related psychosis as FGAs. * D: A STAT head CT is unnecessary in an established dementia patient with gradual sundowning symptoms and no focal neurological deficits or acute trauma. Test-taking pearl: Always select non-pharmacological interventions first for non-emergent behavioral symptoms in older adults with dementia before considering antipsychotic pharmacotherapy. Concept tested: Antipsychotics Black Box Warning and first-line management of BPSD. Question 2. A 76-year-old male with a history of schizophrenia managed with long-term risperidone presents for a routine follow-up appointment. On physical examination, the PMHNP observes involuntary, repetitive darting movements of his tongue and mild lip smacking. The patient is unaware of these movements and denies discomfort. What is the most appropriate management strategy for this patient? A) Administer benztropine 1 mg orally twice daily. B) Perform the Abnormal Involuntary Movement Scale assessment and evaluate for dose reduction or drug switch. C) Increase the risperidone dosage to suppress the involuntary movements. D) Reassure the patient that these movements are transient drug side effects that will self-resolve. Pause. Answer: B. Why correct: The patient presents with classic signs of tardive dyskinesia, a hyperkinetic movement disorder resulting from chronic dopamine receptor blockade. The PMHNP must administer the Abnormal Involuntary Movement Scale to quantify severity and formulate a plan to taper, reduce the dose, or switch to an SGA with lower EPS liability like quetiapine or clozapine. Why each distractor fails: * A: Anticholinergic medications like benztropine treat drug-induced parkinsonism but exacerbate or unmask tardive dyskinesia and should be avoided. * C: Increasing the antipsychotic dose temporarily masks TD symptoms by increasing dopamine blockade, but ultimately worsens long-term striatal dopamine receptor supersensitivity and underlying pathology. * D: Tardive dyskinesia is frequently irreversible if ignored and requires active clinical intervention rather than passive observation. Test-taking pearl: Anticholinergic drugs worsen tardive dyskinesia; do not give benztropine for involuntary oro-facial-lingual movements. Concept tested: Tardive dyskinesia identification, AIMS monitoring, and management. Question 3. The PMHNP is reviewing the medication list of a 78-year-old female with vascular dementia who was recently started on aripiprazole by an outside provider for severe paranoia and physical aggression toward staff. Which baseline monitoring protocol should the PMHNP ensure was performed, and at what frequency should follow-up movement evaluations occur? A) Baseline AIMS evaluation, with repeat assessments every 3 to 6 months. B) Baseline ECG, with repeat QT interval checks every 2 weeks. C) Baseline serum creatinine, with repeat eGFR monitoring every 12 months. D) Baseline liver function tests, with repeat monitoring every month for 6 months. Pause. Answer: A. Why correct: Older adults receiving antipsychotic therapy require a baseline Abnormal Involuntary Movement Scale (AIMS) evaluation prior to treatment initiation, followed by repeat monitoring every 3 to 6 months due to their heightened vulnerability to tardive dyskinesia and extrapyramidal side effects. Why each distractor fails: * B: While ECG monitoring is essential for drugs with high QTc prolongation risk like thioridazine or ziprasidone, biweekly ECGs are not the standard monitoring requirement for aripiprazole in TD surveillance. * C: Renal monitoring is important for lithium, but serum creatinine checks do not evaluate the primary motor risks of antipsychotic therapy in older adults. * D: Monthly liver function testing is indicated for valproate or carbamazepine, not as the primary movement disorder monitoring protocol for aripiprazole. Test-taking pearl: High-risk populations, including older adults, require AIMS assessment every 3 to 6 months rather than the annual monitoring used for younger adults. Concept tested: AIMS screening schedule and high-risk psychotropic monitoring in geriatrics. 🧠 Want to review another specific topic in geriatric psychopharmacology, such as the Beers Criteria for anticholinergics or benzodiazepines in older adults? Next. Topic. Benzodiazepines: Falls and the LOT Exception. Source Coverage Overview. The selected sources (`FITZGERALD - Chap 00_ prequel 2025 rev 12.19.pdf` and `FITZGERALD - SettingtheStageforSuccessonthePMHNPCertificationExam_Transcript.pdf`) do not contain Fitzgerald Chapter 17 ("Prescribing in the Older Adult: Doing More by Doing Less") or the specific leaf topic "Benzodiazepines: Falls and the LOT Exception." These introductory sources cover exam architecture, domain distributions, and the three levels of health prevention. Specific details regarding benzodiazepine pharmacokinetics, hepatic glucuronidation, the **LOT** exception (**lorazepam**, **oxazepam**, **temazepam**), and psychotropic fall mechanisms are missing from these selected files. If you would like me to conduct web research on Fitzgerald Chapter 17 and the **LOT** benzodiazepine exception in older adults, please let me know and I will gather that information for you. Must Know for Boards: Geriatric Care and Prevention Principles. * **Geriatric Exam Weight**: Older adults account for 20% of examination items (27 scored questions) on the AANPCB certification exam [1, 2]. * **Primary Prevention**: Interventions aimed at preventing a health problem or injury before it occurs, such as ensuring adequate home illumination for a 76-year-old patient to prevent falls [3, 4]. * **Secondary Prevention**: Early detection and screening of disease or harm in an asymptomatic state to minimize impact, such as screening a 76-year-old patient for physical, emotional, or financial abuse [3, 4], or ordering a lipid profile to detect metabolic risk [5, 6]. * **Tertiary Prevention**: Managing established clinical disease to prevent complications, disability, or target organ damage, such as adjusting medication therapy or monitoring **lithium** levels in a patient with a known diagnosis [4, 5, 7-10]. * **Lowest Level Principle**: The core primary healthcare principle is to intervene at the lowest level of prevention possible to achieve optimal patient outcomes [11, 12]. Practice Questions from Sources. Question 1. In a 76-year-old man with **post-traumatic stress disorder** and **obsessive-compulsive disorder**, ensuring adequate illumination at home represents which level of prevention? * A) Primary prevention * B) Secondary prevention * C) Tertiary prevention * D) Health restoration **Quick Answer**: Primary prevention aims to prevent an injury or illness before it occurs [3, 4, 13, 14]. **Key Clue**: Ensuring adequate illumination at home [3, 4]. **Best Answer**: A) Primary prevention **Why It Is Correct**: Primary prevention prevents an injury or health problem from occurring. Ensuring adequate lighting removes environmental hazards and prevents falls before an injury happens [3, 4, 13, 14]. **Why the Other Choices Are Wrong**: * **Option A**: Correct answer choice. * **Option B**: Secondary prevention involves early screening or disease detection, such as screening for elder abuse [3, 4, 7, 14]. * **Option C**: Tertiary prevention manages established illness to avoid further complications, such as adjusting psychotropic medications [4, 7-9]. * **Option D**: Health restoration is not one of the standard public health levels of prevention defined in board materials [7, 9, 13, 14]. **Test-Taking Pearl**: Environmental safety modifications that prevent injury before it happens are always primary prevention [3, 4, 13, 14]. **Concept tested**: Levels of prevention in geriatric care [3, 4, 11, 12]. Question 2. In a 76-year-old man with **post-traumatic stress disorder** and **obsessive-compulsive disorder**, screening for physical, emotional, or financial abuse represents which level of prevention? * A) Primary prevention * B) Secondary prevention * C) Tertiary prevention * D) Primordial prevention **Quick Answer**: Secondary prevention focuses on early screening and detection [3, 4, 7, 14]. **Key Clue**: Screening for physical, emotional, or financial abuse [3, 4]. **Best Answer**: B) Secondary prevention **Why It Is Correct**: Secondary prevention detects disease or harm in an early, asymptomatic, or preclinical state to minimize its impact. Abuse screening identifies hidden harm early to intervene promptly [3, 4, 7, 14]. **Why the Other Choices Are Wrong**: * **Option A**: Primary prevention stops the problem before it starts, such as home safety modifications or vaccinations [3, 4, 13, 14]. * **Option B**: Correct answer choice. * **Option C**: Tertiary prevention treats established illness to avoid further complications [4, 7-9]. * **Option D**: Primordial prevention is not a standard level of prevention categorized on the PMHNP exam blueprint [7, 9, 13, 14]. **Test-Taking Pearl**: Any intervention that involves the word "screening" or early detection is secondary prevention [3, 4, 7, 14]. **Concept tested**: Secondary prevention and elder screening [3, 4, 7, 14]. Next Study Step. Review **FITZGERALD - PMHNP-Chap14--OlderAdults_Transcript.pdf** in your notebook for dedicated geriatric clinical content, or let me know if you would like me to conduct web research on Chapter 17 to cover benzodiazepine pharmacokinetics, the **LOT** exception, and fall risks in older adults. 💡 Would you like me to do some web research on Fitzgerald Chapter 17 and the **LOT** exception for benzodiazepines in older adults? Next. Topic. SSRI Selection and Hyponatremia Monitoring. Fitzgerald Chapter 17 Coverage Status. The selected Fitzgerald review sources in this notebook include the introductory prequel module on exam architecture, domain weights, and health promotion levels of prevention [1-3]. These specific files do not contain Fitzgerald Chapter 17 or details regarding **SSRI** selection and **hyponatremia** monitoring in older adults. Here is the essential geriatric exam blueprint scope, safety rules, and health promotion framework established in these selected Fitzgerald materials. Bottom Line. - The **AANPCB** certification exam designates 20% of test questions (27 scored items) specifically to the older adult population [4, 5]. - The **ANCC** examination evaluates psychiatric and physical health concepts across the entire lifespan from infant to frail elder [6, 7]. - Intervening at the lowest level of prevention possible is a core board principle [3, 8]. - **Primary prevention** stops disease before onset through health promotion, education, or injury reduction [9, 10]. - **Secondary prevention** identifies preclinical or asymptomatic illness through screening tools and routine lab checks [10, 11]. - **Tertiary prevention** manages established illness to reduce complications, adjust medication regimens, or minimize target organ damage [11, 12]. High-Risk Geriatric Considerations and Levels of Prevention. Primary Prevention in Older Adults. - **Safety alert**: Environmental risk reduction prevents acute physical trauma in vulnerable older adults [13, 14]. - **First-line**: Ensuring adequate home illumination for a 76-year-old patient with **PTSD** is primary prevention because it prevents falls before an injury occurs [13, 14]. - **Immunizations**: Administering the annual influenza vaccine to a 66-year-old patient with **schizophrenia** represents primary disease prevention [15, 16]. Secondary Prevention in Older Adults. - **Board trap**: Confusing routine screening with treatment management. Screening tests always represent secondary prevention [10, 11]. - **First-line**: Screening a 76-year-old male for physical, emotional, or financial abuse is secondary prevention [13, 14]. - **Lab checks**: Obtaining a lipid panel or routine blood pressure check to catch asymptomatic metabolic or cardiovascular illness early is secondary prevention [10, 11, 14, 17]. Tertiary Prevention in Older Adults. - **First-line**: Adjusting psychotropic medication therapy in a 66-year-old patient with **schizophrenia** to enhance symptom regulation represents tertiary prevention [15, 16]. - **Disease management**: Accessing an Employee Assistance Program or modifying established treatment to prevent disease progression is tertiary prevention [11, 12, 18-20]. Fitzgerald Practice Questions from Selected Sources. Question 1. In a 76-year-old man with post-traumatic stress disorder and obsessive-compulsive disorder, ensuring adequate illumination at home is an example of which level of prevention? A) Primary prevention B) Secondary prevention C) Tertiary prevention D) Anticipatory guidance Pause. Answer: A Why correct: Ensuring adequate illumination reduces fall risk and prevents injury before a health problem occurs, which meets the exact criteria for primary prevention [9, 10, 13, 14]. Why distractors fail: - A: This option is correct. - B: Secondary prevention involves screening for asymptomatic disease, not physical safety modifications [10, 11]. - C: Tertiary prevention manages established disease to prevent further complications or organ damage [11, 12]. - D: Anticipatory guidance is a teaching strategy rather than a formal health prevention level classification [20, 21]. Question 2. In a 76-year-old man with post-traumatic stress disorder, screening for physical, emotional, or financial abuse represents which level of prevention? A) Primary prevention B) Secondary prevention C) Tertiary prevention D) Health promotion Pause. Answer: B Why correct: Screening tests designed to detect early, asymptomatic, or hidden conditions to minimize impact are secondary prevention [10, 11, 13, 14]. Why distractors fail: - A: Primary prevention stops a health problem before it develops rather than screening for existing hidden abuse [9, 10]. - B: This option is correct. - C: Tertiary prevention involves managing known, diagnosed conditions to prevent further deterioration [11, 12]. - D: Health promotion is part of primary prevention, whereas screening specifically defines secondary prevention [9-11]. Question 3. In a 66-year-old woman with schizophrenia, adjusting psychiatric medication therapy to enhance symptom regulation is an example of which level of prevention? A) Primary prevention B) Secondary prevention C) Tertiary prevention D) Disease screening Pause. Answer: C Why correct: Adjusting ongoing therapy for an established chronic psychiatric diagnosis minimizes negative outcomes and prevents disease-induced complications, which is tertiary prevention [11, 12, 15, 16]. Why distractors fail: - A: Primary prevention occurs before a disease is diagnosed to prevent its initial onset [9, 10]. - B: Secondary prevention focuses on early screening and detection before clinical symptoms prompt treatment adjustment [10, 11]. - C: This option is correct. - D: Disease screening is synonymous with secondary prevention, not treatment adjustment [10, 11]. Next Study Step. Review Chapter 14 (Older Adults) or conduct web research if you would like to gather detailed Chapter 17 material on **SSRI** selection, **hyponatremia**, and **SIADH** monitoring in older adults. 💡 Want me to do some web research on Fitzgerald Chapter 17 guidelines for SSRI selection and hyponatremia monitoring in geriatric patients? Next. End of this drive.